Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

A new molecular culprit for type II diabetes, Alzheimer’s and Parkinson’s

22.10.2003


Therapies for Alzheimer’s, Parkinson’s and type II diabetes should be directed toward a new molecular culprit — the precursor to the clumps of abnormal proteins that have garnered attention for the last century.



Israeli scientists say they have solid evidence that the precursor molecules — called protofibrils — are the problem molecules in type II diabetes, and their results support a similar mechanism for Alzheimer’s and Parkinson’s. Further, they say that the current focus on breaking up the abnormal clumps of protein — called fibrils — may in fact be doing more harm than good.

The report appeared in the Sept. 23 edition of Biochemistry, a peer-reviewed journal of the American Chemical Society, the world’s largest scientific society.


Proteins are the chemical workhorses of the body. These long chains of amino acids fold into myriad forms, but they must assume the right three-dimensional structure to function properly. Misfolded proteins are the basis of a number of seemingly unconnected diseases, including age-related diseases like type II diabetes, Alzheimer’s and Parkinson’s, as well as "mad cow" (BSE) and other prion diseases.

Despite many years of investigation, the actual mechanism of misfolding has eluded researchers, leaving them without the understanding necessary to develop effective treatments or even properly diagnose the diseases.

The most popular theory has revolved around long clumps of misfolded proteins known as amyloid fibrils that kill cells in patients. Therapeutic efforts have focused on breaking up these deposits. In Alzheimer’s they are called amyloid plaques; in Parkinson’s they are called Lewy bodies; in type II diabetes they are called islet amyloid deposits and occur in the "islets of Langerhans," the area of the pancreas where insulin is produced and regulated.

"Type II diabetes is one of the most common amyloid-related diseases," says Ehud Gazit, Ph.D., a researcher at Tel Aviv University in Israel and lead author of the study. "The Centers for Disease Control and Prevention in Atlanta estimate that more than 18 percent of American adults older than age 65 have diabetes, almost entirely of type II." As the life expectancy of people around the world continues to increase, this and other age-related diseases will become an even greater public health concern, he says.

Scientists have previously suggested that mature fibrils of the amyloid polypeptide protein — the key component of the islet deposits — are toxic to cells in the pancreas that produce insulin, attacking through tiny holes in the cell membrane. Gazit and his colleagues, graduate student Yair Porat and Sofiya Kolusheva and Raz Jelinek from Ben Gurion University, studied the interactions between the protein and cell membrane. They discovered that smaller structures formed prior to the mature fibrils, called protofibrils, are more likely to get through the membrane, and may therefore be the more toxic species.

In the past few years, other scientists have noticed the effects of protofibrils while studying Alzheimer’s and Parkinson’s, but the notion that they may be the main culprits is fairly new. Earlier this summer in another Biochemistry paper, Peter Lansbury of Harvard University suggested a possible therapeutic strategy for Parkinson’s based on stopping the formation of protofibrils.

"A very interesting point is the striking similarity between these assemblies and the structures observed in the cases of Alzehimer’s disease and Parkinson’s disease," Gazit says. The new study offers solid experimental evidence of the phenomenon in type II diabetes, and demonstrates a common thread among the three diseases.

The majority of research continues to focus on mature fibrils, but this could prove to be dangerous if the new protofibril mechanism is correct, according to Gazit. Breaking up the large amyloid deposits may actually increase the number of protofibrils, thus increasing the level of toxicity to the body.

Gazit’s new research on protofibrils is still in the early stages, but it suggests the need for a shift in focus from breaking up mature fibril deposits to inhibiting the earlier stage of protofibril formation. His group has designed several potential inhibitor molecules and they are currently testing their potency.

Michael Bernstein | EurekAlert!
Further information:
http://www.acs.org/

More articles from Health and Medicine:

nachricht Usher syndrome: Gene therapy restores hearing and balance
25.09.2017 | Institut Pasteur

nachricht MRI contrast agent locates and distinguishes aggressive from slow-growing breast cancer
25.09.2017 | Case Western Reserve University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: LaserTAB: More efficient and precise contacts thanks to human-robot collaboration

At the productronica trade fair in Munich this November, the Fraunhofer Institute for Laser Technology ILT will be presenting Laser-Based Tape-Automated Bonding, LaserTAB for short. The experts from Aachen will be demonstrating how new battery cells and power electronics can be micro-welded more efficiently and precisely than ever before thanks to new optics and robot support.

Fraunhofer ILT from Aachen relies on a clever combination of robotics and a laser scanner with new optics as well as process monitoring, which it has developed...

Im Focus: The pyrenoid is a carbon-fixing liquid droplet

Plants and algae use the enzyme Rubisco to fix carbon dioxide, removing it from the atmosphere and converting it into biomass. Algae have figured out a way to increase the efficiency of carbon fixation. They gather most of their Rubisco into a ball-shaped microcompartment called the pyrenoid, which they flood with a high local concentration of carbon dioxide. A team of scientists at Princeton University, the Carnegie Institution for Science, Stanford University and the Max Plank Institute of Biochemistry have unravelled the mysteries of how the pyrenoid is assembled. These insights can help to engineer crops that remove more carbon dioxide from the atmosphere while producing more food.

A warming planet

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Fraunhofer ISE Pushes World Record for Multicrystalline Silicon Solar Cells to 22.3 Percent

25.09.2017 | Power and Electrical Engineering

Usher syndrome: Gene therapy restores hearing and balance

25.09.2017 | Health and Medicine

An international team of physicists a coherent amplification effect in laser excited dielectrics

25.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>